evo真人视讯

Silk Industry Leader Wensli Expert Delegation Visits Cell Valley Group

Date:01-11  Hits:  Belong to:Corporate News

From January 8 to 9, 2026, a delegation from Hangzhou Wensli Silk Culture Co., Ltd. (listed on the Growth Enterprise Market), including Deputy General Manager Bao Qiang, Chief Engineer Lou Yongqiang, and Senior Advisor Professor Min Sijia from Zhejiang University, visited Cell Valley Group for technical exchanges. Cell Valley Group's Chairman and General Manager Professor Shi Yuanyuan, Chief Scientist Professor Wang Jianxun, R&D Department Head Zhao Lijun, Marketing Department Head Sun Rui, and General Office Director Han Shu participated in the discussions and accompanied the visit. 

On the first day, the visiting guests toured Deep Harbour Cell Valley, the international business and service headquarters of Cell Valley Group, gaining a preliminary understanding of the company's independently developed human mesenchymal stem cell-derived exosome products and their industrialization layout. On the following day, the delegation visited the R&D and production headquarters, Shenzhen Cell Valley, for an on-site inspection of the entire GMP-standard exosome preparation process, covering core aspects including  process research and development, scale-up production, quality control, lyophilized formulations, and cold chain logistics.


Both parties have now established a regular communication mechanism, laying a solid foundation for future strategic cooperation.

 


About Wensli


Hangzhou Wensli Silk Culture Co., Ltd. was founded in Hangzhou in 1975 and is a leading enterprise in China's silk industry. It was listed on the Growth Enterprise Market in 2021 (301066). Deeply rooted in silk cultural creativity, the company possesses core technologies such as waterless printing and AI pattern large models. It has repeatedly served international events including the Olympic Games and the G20 Summit. With strategic arrangements in biotechnology and asset operations, Wensli is ranked among China's Top 500 Private Enterprises, empowering the upgrading of the silk industry through technology and culture.


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@rodael.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Bottom Navigation
Shenzhen Cell Valley Biopharmaceutical Co., Ltd.​​ is a comprehensive one-stop outsourcing service provider in China focused on the cell and gene therapy industry. It is also one of the first CRO/CDMO companies in the country to possess GMP industrial production capabilities for clinical-grade retroviral vectors . The company is a major public technical service platform construction project for CRO/CDMO in Shenzhen and is included among the city's latest announced "20+8" strategic emerging industry projects.Shenzhen Cell Valley has the capability for standardized and industrialized production of GMP-grade cell products such as CAR-T cells. Its primary production lines include those for various cell products like CAR-T, CAR-NK, CAR-M, γδT, TIL, and TCR-T. Additionally, the company operates production lines for various viral vectors, including RVV, LVV, non-viral vectors, and AAV, as well as for cellular raw materials used in producing therapeutics such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses, and vaccines.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书:(粤)-非经营性-2022-0426  Technical Support:YouDian Software